Sunday, January 26, 2020

Global Anti-Snoring Devices and Snoring Surgery Market Size is anticipated to reach over USD 2,461. Million by 2026

New York City, 27 January 2020: The Global Anti-Snoring Devices and Snoring Surgery Market Size is anticipated to reach over USD 2,461. Million by 2026 according to a new research published by Polaris Market Research.
Snoring is a common sleeping condition caused owing to the airway blockage. Snoring is a symptom or indication of obstructive sleep apnea. The airway block is originated from various causes such as tonsil enlargement, nasal congestion, or improper mouth anatomical structure, which narrow down the passageway of air flow and breathing gets more or less clogged. In addition, usage of sedatives or antidepressant drugs, alcohol consumption, obesity, smoking, and allergies are another factors associated with snoring.
According to the World Health Organizations, currently around 100,000,000 people are suffering snoring problems globally and this problem is highly proportional to the age and hugely found in the age group of 55-60 years. Moreover, according to the American Sleep Association, approximately 50-70 million people have sleep ailments in the U.S. and out of that around 48% are diagnosed to have snoring. The treatment of cumulative affliction of snoring is needed to prevent the risk of obesity, diabetes, mental health issues due to sleep deprivation, gastroesophageal reflux disease, heart diseases, and other complications.
The increase in the number of people suffering snoring and larger rising need for budget-friendly, efficacious, and user-friendly, anti-snoring devices are the factors increasing the global anti-snoring devices and snoring surgery market. In addition, even though anti-snoring devices are the prime revenue generator in the global anti-snoring devices and surgery market, it is also anticipated that more people worldwide will undertake surgery to address the snoring disorder.
The global anti-snoring devices and snoring surgery market are segmented on the basis of device type, surgical procedure, and geography. On the basis of device type, the global market is categorized into oral applications, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, and Expiratory Positive Airway Pressure. Among these segments, nasal products such as nasal strips and nasal cones are the most popular and widely used as these devices are easy to use and are convenient.
On the basis of surgery type the global anti-snoring devices and snoring surgery market is further categorized into uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. From the surgery type segment, somnoplasty is estimated as the fastest growing segment owing to factors such as minimally invasive, comparatively low surgery cost, less painful, and fewer complications in comparison to the conventional surgical procedures.

North America is estimated to hold the dominant position in the anti-snoring devices and snoring surgery market, due to the growing occurrence of snoring disorders in the region. For instance, according to American Sleep Foundation 2017, approximately 90 million American were estimated to be affected by one or the other respiratory disorder leading to snoring. As an outcome increasing the incidence of snoring is anticipated to increase the demand for its devices and treatment, fueling anti-snoring devices and snoring surgery market. The Asia Pacific is anticipated to dominate the market in the forecast period, owing to growing number of people suffering obesity and respiratory ailments, leading to augment the growth of the anti-snoring devices and snoring surgery market during the forecast period.
Some major key players in global anti-snoring devices and snoring surgery market includes Apnea Sciences Corporation, Pure Sleep Company, SomnoMed Ltd., Airway Management, Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline Plc, and Meditas Ltd., among others.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com


Posted by at No comments:
Labels: , , ,

Thursday, December 5, 2019

catheters market Exclusive insight on Transformation 2026

New York, NY 06 Dec 2019: According to a new report published by Polaris Market Research, the global catheters market is anticipated to reach USD 56.5 billion by 2025. In 2017, by product type, cardiovascular catheter segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the catheter market.

Catheters are thin tubes made up of plastic, nylon, polyvinyl chloride (PVC), and silicon rubber. Catheters are majorly used in catheterization while surgical procedures like angioplasty, and neurosurgery. The catheters market is primarily driven by continuous growth in the population suffering from cardiovascular disorders and diabetes. Presently, various countries showed the growth in number of patients suffering from hypertension and diabetes which is braced by factors such as smoking, drinking and sedentary lifestyle of the population. In addition, favorable reimbursement policies, increasing demand for minimal invasive surgeries, and technological advanced catheter with high effectiveness by its use would spur the global catheter market during the forecast period. on other hand, the wide application of catheter in various surgeries such as angioplasty would also push this market. The reimbursements by the Medicaid program that provide approximately 100 catheters per month to add the growth of catheter market in the future.


Cardiovascular Catheters, holds a major share in the global catheter market. The cardiovascular catheter market is further segmented as PTCA balloon catheters, IVUS catheters, PTA balloon catheters, electrophysiological catheters, and others. The growth of cardiovascular catheters is majorly driven by the increasing incidences of cardiovascular diseases supporting the growth of cardiovascular interventional procedures. While, urological catheter holds the second largest segment with largest revenue. The factors contributing for the growth of urological market are continuous technological advancements, and increasing prevalence of urological diseases in the coming year.

Geographically, North America holds a dominating position in the global catheter market followed by Europe and Asia Pacific. The growth in the North America catheter market is driven by the presence of refined health infrastructure, high volume of catheterization in medical procedures, high healthcare expenditure by the individuals, and high level of patient awareness about the use catheters. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these devices in the developing countries, growing technological advancements pertaining the development of new-catheter devices, and improving healthcare expenditure would influence the catheter market in Asia Pacific during the forecast period.

Do you have questions or special requirements? Ask our industry experts: https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/speak-to-analyst

The leading companies operating in this industry include Johnson & Johnson Inc., Abbott Laboratories, Becton, Dickson and Company, B. Braun Melsungen AG., Medtronic plc., Boston Scientific Corporation, Cook Group Incorporated, Teleflex Incorporated, Cardinal Health Inc., Smiths Medical, Arrow International Inc., Edward Life Science Corporation, and Coloplast.

Key Findings from the study suggest products available in the market are continuously concentrating on the technological advancements that will reduce the side effects caused by the use of catheters. The leading companies while developing new products considers the factors such as increasing disposable income, and untapped market potential. North America is presumed to dominate the global catheter market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

About Polaris Market Research
We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com



Posted by at No comments:
Labels: ,

Thursday, October 10, 2019

Contact Lenses Market Share, Scope, Growth Opportunities Analysis and Forecast 2026

New York, 10, Oct 2019: According to a new study published by Polaris Market Research the global contact lenses market is anticipated to reach USD 18.9 billion by 2026. Once of the key factor driving the contact lenses market is to enhance aesthetic appearance by using them as fashion accessory particularly, by the youth population. Also, constant development in technology of product materials and given a boost to colored or decorative contact lenses, which is further anticipated to influence the demand. Moreover, the rising incidences of visual imparities such as myopia, presbyopia, hyperopia and astigmatism is propelling the market growth. The World Health Organization, in 2015, estimated that approximately 1.9 billion people across the globe have been affected by myopia and the number is anticipated to be more than 2 billion by 2020. Thus, the demand for contact lenses during the forecast period will experience a growth.

The contact lenses manufacturers and vendors are appealed by the high profit margins offered by the contact lenses thus, boosting its manufacturing as well as enhancing the network of distribution. Also, advancements in technology in form of material will provide new opportunities to the manufacturers with time. By type segment, the Rigid Gas Permeable (RGP) Lenses was valued over USD 800 million in 2017 owing to factors including, sharp vision, high oxygen permeability, cost-effectiveness in the long run, and durability.
The contact lenses market by usage type is segmented into Corrective, Therapeutic, Cosmetic, Prosthetic, and Lifestyle-oriented. The corrective lenses usage segment is currently growing at a CAGR of more than 6.2%. The demand is attributed to its various applications. Whereas, cosmetic lenses segment is expected to witness high growth during the forecast period. On the basis of design, the hybrid lens segment is anticipated to experience a noteworthy growth as it is a combination of both soft lenses and rigid gas permeable lenses. Thus, it provides comfort of soft lenses coupled with the visual clarity offered by rigid gas permeable lenses. The growth of hybrid lenses segment is expected to propel with the increased demand from people with keratoconus and astigmatism conditions.

The North America market holds the largest share owing to presence of better eye care treatment facilities as increasing elderly population. Although, the Asia Pacific market is expected to bolster with a high CAGR attributed to the increased awareness regarding contact lenses among the population as well as their increasing ability for healthcare spending.
The key strategies adopted by the market players include long-term partnerships among the other players in supply chain particularly, distributors and suppliers with an aim to increase their geographical footprint. For instance, in 2016, Vision Direct Group Ltd. was acquired by Essilor International S.A. for the enhancement of its online retailing business presence. Major industry players include Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Bausch + Lomb, Incorporated, Carl Zeiss AG, CooperVision, Inc., Contamac U.S., Inc., Hoya Corporation, Essilor International S.A., Medennium and Johnson & Johnson Vision Care, Inc. among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Posted by at No comments:
Labels: , , , , ,

Wednesday, October 9, 2019

CBD Oil Market Reviewed for 2019 with Industry Outlook to 2026

New York, 09, Oct 2019: The global CBD Oil market size is expected to reach USD 3,095.3 million by 2026 according to a new study by Polaris Market Research. The report “CBD Oil Market Share, Size, Trends, Industry Analysis Report By Product (Hemp Based and Marijuana Based), By Application (Pharmaceuticals, Food & Beverages, Cosmetics and Others); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, Others); By Regions, Segments & Forecast, 2019 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.


Flexibility of CBD oil thus resulting in a wide variety of applications, health benefits such as ability to boost cognitive abilities, anti-inflammatory properties, among others, and information outburst through a variety of platforms including social media are benefitting the CBD oil market demand. Development of novel products such as CBD oil infused honey and aggressive marketing strategies adopted to promote the same is also expected to benefit the overall market growth.

Polaris Market research has segmented the CBD oil market report on the basis of product, application, distribution channel and region

In the past, CBD related research was restricted to the treatment of severe diseases such as cancer and epilepsy and this put limitations on the usage in other avenues such as cosmetics. However, with multinationals taking interest in the product, the research horizon widened and properties such as anti-inflammatory were discovered which led to the usage of the oil not just by health provider brands but by wellness brands as well. This widened usage coupled with the rising preference for preventive healthcare has fueled CBD oil market growth across the globe.

The key players in the market for CBD oil include ENDOCA, Isodiol, Medical Marijuana, Cannoid., Canopy Growth Corporation, Elixinol Group, Folium Biosciences, Diamond CBD, NuLeaf Naturals, PharmaHemp, Aphria Inc. and Gaia Botanicals among others. Development of distribution channels, novel product development and aggressive marketing campaigning are some of the success factors in the industry.

To customize the study according to your specific requirements please click : https://www.polarismarketresearch.com/industry-analysis/cbd-oil-market/request-for-customization
  
Rise in millennial population is also benefitting the market demand. Bath soaps, lip gloss, face creams, lotions, serums, medicines for curing muscle pains are some of the products that are appealing to this segment of customers. Furthermore, companies are adopting SEO centric strategies to create online awareness regarding CBD oil products among these millennials. This category of customers is looking to boost their cognitive ability or health functions through usage of novel ways and CBD oil infused products fits this demand perfectly.

North America emerged as the largest market for CBD oil in 2018 and is expected to maintain its dominance over the forecast period. Strong presence of companies in the US, high awareness regarding CBD oil usage, availability of a wide variety of products as well as efficient distribution channels leading to easy availability are some of the factors benefitting the regional market demand. Acquisition of companies having good brand recall and brand awareness by multinationals is a key market scenario in the region.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us






Posted by at No comments:
Labels: , , , , ,

Thursday, October 3, 2019

Gout Therapeutics Market Size, Production, Revenue, Growth & Analysis by Regions


New York City, 03 Oct 2019 : The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report published by Polaris Market Research. The report Gout Therapeutics Market Size, Share, Trends & Analysis Report, By Drug Class (Urate-Lowering Agents, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Colchicine); By Disease Condition (Chronic Gout, Acute Gout); By Region, Segment Forecast, 2019 – 2026 provides in depth analysis of the current and future market trends.

The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder. 
Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.
As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share.  
NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.
Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market. 
 About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Contact us : Web: http://www.polarismarketresearch.com
Posted by at No comments:
Labels: , , , , ,

Sunday, September 22, 2019

Genomics in Cancer Care Market Based On Capacity, Technological Advancement, Production and Growth Rate

New York City, 23 Sep 2019:The global genomics in cancer care market size is anticipated to reach USD 14.6 billion by 2025 growing at a CAGR of 17.7% from 2019 to 2025 according to a new report published by Polaris Market Research. The report ‘Genomics in Cancer Care Market Share, Size, Trends, & Industry Analysis Report, By Product type (Consumables, Instruments, Services); By Technology, By Application; By End Use; and By Region: Segment Forecast, 2019–2025’ provides insights on the current market scenario and the future prospects.

In 2018, by product type, instrument segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the global market.
The market is primarily driven by increasing prevalence of cancer patients globally, and rising demand for diagnostic coupled with the availability of cost effective and technologically advanced technology. Additionally, awareness and growing preference for personalized medicines is also influencing the market growth. Moreover, continuous investment on research and developments by the biotechnology & pharmaceutical companies would also fuel the market growth.


Product segment is further sub-segmented into consumables and reagents, instruments, and services. Instruments market holds the major share in the market owning to the rapid technological advancements, and continuous efforts by the manufacturers for providing digitalization in the instruments for its easy use. While consumables and reagents hold second largest position for market followed by the service sub segment.
Based on technology, the market is segmented as genome sequencing, PCR, microarray nucleic acid extraction and purification. Genome sequencing holds the major market share in 2017, and would continue to experience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results, and rising awareness for its use in cancer diagnosis. Moreover, advantages like growing demand for cost-effective technologies, and flexibility in this technique would also influence the growth of genome sequencing market.

On the basis of application, the market is further segmented as diagnostics, personalized medicines, drug discovery, and Research. This application is majorly used for diagnosis of cancer. Diagnostics holds the largest market share which is majorly attributed to the growing number of cancer patients worldwide.
Research institute is the largest segment as an end user for the market, and would hold dominating position during the forecast period. The growth of genomics market in cancer care is primarily driven by the need for accurate screening techniques that gives to the point diagnosis of cancer.


Geographically, North America holds a dominating position in the global genomics in cancer care market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, large pool of patients suffering from cancer, and high healthcare expenditure by the individuals. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these technologies and improving research and development expenditure by the biopharma industries.
The leading companies operating in this industry include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex.
Key Findings from the study suggest technology available in the market are continuously concentrating on the technological advancements that will reduce the efforts and provide with accurate diagnosis of cancer. The leading companies while developing new technologies considers the factors such as increasing awareness for the use of this technology, and reaching the untapped market. North America is presumed to dominate the global market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.


About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us


Posted by at No comments:
Labels: , ,

Monday, August 26, 2019

Optical Coherence Tomography Market Set for Rapid Growth During 2026

New York, NY 26 Aug 2019 The Global Optical Coherence Tomography Market (OCT) Size is anticipated to reach over USD 2,179.75 Million by 2026 according to a new research published by Polaris Market Research. Optical Coherence Tomography (OCT) methods are operative optical diagnostics techniques that cast a 2D as well as the 3D outlook of the retina to help ophthalmological assessments and treatments.  The Optical Coherence Tomography (OCT) Market is basically impelled by the differential need for these methods across several areas of life science and healthcare. The OCT market has been emphasized by the advancement in technologies, furthered by the increasing significance of medical applications in the current scenario.

The range of Optical Coherence Tomography is not limited to ophthalmology and has extended across other medical application such as nephrology, dermatology, and oncology. This factor has amplified the growth scenarios of the Optical Coherence Tomography (OCT) which is anticipated to show intense growth in the forecast period.  The escalation of pathology has also become a devoted contributor to market growth as OCT methods could be employed in the pensive study of micro-level diseases. Furthermore, the non-intrusive nature of OCT has made this technique a prime choice of the medical community for ophthalmic imaging.


The Optical Coherence Tomography (OCT) market has extended its area to the study of ailments such as cardiovascular disruptions, diabetes, esophageal problems, non-melanoma skin cancer, and prostate cancer. This is a significant standpoint for the market as the increasing occurrence of such disorders would create a widespread demand for OCT products. In addition, the emerging economies such as China, Japan, and India have seen operational variations in their healthcare sector which is making developing progress in that regions. This proliferates the demand for OCT devices further propelling the market growth.

 Some major key players in global Optical Coherence Tomography (OCT) Market include Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Topcon Medical Systems Inc. and Thorlabs Inc. among others.
  
The global Optical Coherence Tomography (OCT) Market is segmented on the basis of technology, type, application, and geography. On the basis of technology, the global Optical Coherence Tomography (OCT) Market is segmented into Time Domain Optical Coherence Tomography (TDOCT), Frequency Domain Optical Coherence Tomography (FD-OCT), and Spatially Encoded Frequency Domain Optical Coherence Tomography. The Spatially Encoded Frequency Domain Optical Coherence Tomography is further categorized into Spectral Domain Optical Coherence Tomography (SDOCT) and Fourier Domain Optical Coherence Tomography (FDOCT).

On the basis of type, the global Optical Coherence Tomography (OCT) Market is segmented into Catheter-based OCT devices, Doppler OCT devices, Handheld OCT devices, and Tabletop OCT devices. In 2017, the handheld type segment was estimated to dominate the market. The dominance is attributed to the higher product penetration in developed regions such as U.S., U.K., Germany, and Brazil.

  
On the basis of application, the global Optical Coherence Tomography (OCT) Market is segmented into Ophthalmology, Cardiovascular, Oncology, Dermatology, and others. In 2017, ophthalmology segment is estimated to dominate the market growth. Introduction of higher performing devices with accurateness, improved performance, and easiness of use coupled with the supplementing occurrences of choroidal and retinal disorders is the vigorous impact rendering factor enhancing the market growth.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world


Posted by at No comments:
Labels: , , , ,
Subscribe to: Comments (Atom)